Risperdal Consta

In the US, Risperdal Consta (risperidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Schizophrenia.

US matches:

• Risperdal Consta

UK matches:

• RISPERDAL CONSTA 25, 37.5 and 50 mg powder and solvent for prolonged-release suspension for intramuscular injection (SPC)

Ingredient matches for Risperdal Consta

Risperidone

Risperidone is reported as an ingredient of Risperdal Consta in the following countries:

• Antigua & Barbuda


• Argentina


• Aruba


• Austria


• Bahamas


• Barbados


• Bermuda


• Brazil


• Cayman Islands


• Chile


• Czech Republic


• Finland


• France


• Georgia


• Germany


• Grenada


• Guyana


• Iceland


• Indonesia


• Israel


• Jamaica


• Japan


• Malaysia


• Malta


• Mexico


• Netherlands


• Netherlands Antilles


• Norway


• Philippines


• Portugal


• Saint Lucia


• Saint Vincent & The Grenadines


• Slovenia


• South Africa


• Spain


• Suriname


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.